449 related articles for article (PubMed ID: 35453518)
1. HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers.
Proulx J; Ghaly M; Park IW; Borgmann K
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453518
[TBL] [Abstract][Full Text] [Related]
2. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
Lewden C; Salmon D; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
Int J Epidemiol; 2005 Feb; 34(1):121-30. PubMed ID: 15561752
[TBL] [Abstract][Full Text] [Related]
3. AIDS-related malignancies: revisited.
Cáceres W; Cruz-Amy M; Díaz-Meléndez V
P R Health Sci J; 2010 Mar; 29(1):70-5. PubMed ID: 20222338
[TBL] [Abstract][Full Text] [Related]
4. The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review.
Franzetti M; Ricci E; Bonfanti P
Curr HIV Res; 2019; 17(1):1-12. PubMed ID: 30919779
[TBL] [Abstract][Full Text] [Related]
5. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
6. HIV-related Malignancies and Mimics: Imaging Findings and Management.
Javadi S; Menias CO; Karbasian N; Shaaban A; Shah K; Osman A; Jensen CT; Lubner MG; Gaballah AH; Elsayes KM
Radiographics; 2018; 38(7):2051-2068. PubMed ID: 30339518
[TBL] [Abstract][Full Text] [Related]
7. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.
Ando K; Shimomura A; Watanabe K; Tsukada K; Teruya K; Gatanaga H; Shimizu C
Cancer; 2024 May; ():. PubMed ID: 38718047
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous Regression of Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma in an HIV-Positive Patient: A Case Report and Literature Review.
Khaw ELY; Gan WF; Zaidan NZ
Cureus; 2024 Mar; 16(3):e55790. PubMed ID: 38586647
[TBL] [Abstract][Full Text] [Related]
9. Update on non-acquired immunodeficiency syndrome-defining malignancies.
Chiao EY; Krown SE
Curr Opin Oncol; 2003 Sep; 15(5):389-97. PubMed ID: 12960522
[TBL] [Abstract][Full Text] [Related]
10. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
11. Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era.
Brugnaro P; Morelli E; Cattelan F; Petrucci A; Panese S; Eseme F; Cavinato F; Barelli A; Raise E
World J Virol; 2015 Aug; 4(3):209-18. PubMed ID: 26279983
[TBL] [Abstract][Full Text] [Related]
12. AIDS malignancies.
Arora A; Chiao E; Tyring SK
Cancer Treat Res; 2007; 133():21-67. PubMed ID: 17672037
[TBL] [Abstract][Full Text] [Related]
13. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
Marin B; Thiébaut R; Bucher HC; Rondeau V; Costagliola D; Dorrucci M; Hamouda O; Prins M; Walker S; Porter K; Sabin C; Chêne G
AIDS; 2009 Aug; 23(13):1743-53. PubMed ID: 19571723
[TBL] [Abstract][Full Text] [Related]
14. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
[TBL] [Abstract][Full Text] [Related]
15. [Research on the causes of death associated with combined effects of HBV and HCV infection in patients with acquired immunodeficiency syndrome].
Guo PL; Cai WP; Chen XJ; He HL; Hu FY; Tang XP; Li LH
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):495-498. PubMed ID: 30317770
[No Abstract] [Full Text] [Related]
16. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression.
Ganesan M; Poluektova LY; Kharbanda KK; Osna NA
World J Gastroenterol; 2019 Jan; 25(4):398-410. PubMed ID: 30700937
[TBL] [Abstract][Full Text] [Related]
18. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
19. Cancer prevention in patients with human immunodeficiency virus infection.
Valanikas E; Dinas K; Tziomalos K
World J Clin Oncol; 2018 Sep; 9(5):71-73. PubMed ID: 30254961
[TBL] [Abstract][Full Text] [Related]
20. HIV/AIDS Associated Lymphoma: Review.
Berhan A; Bayleyegn B; Getaneh Z
Blood Lymphat Cancer; 2022; 12():31-45. PubMed ID: 35517869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
